# Isolator Synergy Clamps

Type: Product

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/isolator-synergy-clamps
Canonical HTML page: https://getfinancebrief.com/entity/isolator-synergy-clamps

## Timeline

- **2026-09-08**: CTO executes sale of 3,657 shares — Privitera sold 3,657 shares at a weighted average price of $55, generating approximately $201,135.
- **2026-09-08**: AtriCure closes at $53.73 — Post-transaction stock close values Privitera's remaining ~147,000 shares at about $7.9 million.
- **2026-02**: Rule 10b5-1 trading plan adopted — Salvatore Privitera established a pre-arranged trading plan for future stock sales, setting execution terms months before the September transaction.

## Recent coverage (1 stories)

### ATRC Insider Sale: CTO Offloads $201K as Stock +49%
2026-09-13 04:04:11 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

AtriCure's CTO sold $201,135 in stock at $55 per share as ATRC rallied 49% over 12 months. The 10b5-1 plan reduces negative signaling, but the sale raises valuation questions amid thin net margins.
Full story: https://getfinancebrief.com/story/atricure-cto-sale-finance-insider-trading

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.